ES2074263T3 - Derivados 1-(alcoxiiminoalquil)imidazol sustituidos. - Google Patents

Derivados 1-(alcoxiiminoalquil)imidazol sustituidos.

Info

Publication number
ES2074263T3
ES2074263T3 ES91904730T ES91904730T ES2074263T3 ES 2074263 T3 ES2074263 T3 ES 2074263T3 ES 91904730 T ES91904730 T ES 91904730T ES 91904730 T ES91904730 T ES 91904730T ES 2074263 T3 ES2074263 T3 ES 2074263T3
Authority
ES
Spain
Prior art keywords
sub
alkyl
hydrogen
derivatives
alcoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91904730T
Other languages
English (en)
Inventor
Paolo Cozzi
Maria Menichincheri
Arsenia Rossi
Corrado Ferti
Patricia Salvati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909004347A external-priority patent/GB9004347D0/en
Priority claimed from GB909027551A external-priority patent/GB9027551D0/en
Application filed by Pharmacia SpA filed Critical Pharmacia SpA
Application granted granted Critical
Publication of ES2074263T3 publication Critical patent/ES2074263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Epoxy Resins (AREA)

Abstract

DERIVADOS DE 1-(ALCOXI-IMINOALQUIL) IMIDAZOL QUE TIENEN LA FORMULA (I) EN DONDE R ES HIDROGENO O ALQUILO C SUB 1 4; A ES ALQUILENO C SUB 1 OR FENILO OPCIONALMENTE SUSTITUIDO POR HALOGENO O TRIFLUOROMETILO; R ES (A) HIDROGENO O UN RADICAL DE HIDROCARBURO C SUB 1 C SUB 10; (B) UN ARILO O GRUPO ALQUILO DE ARILO C SUB 1 ALOGENO, TRIHALOMETILO, ALQUILO C SUB 1 SUB 2 C SUB 4, ALQUILTIO C SUB 1 C SUB 8, ALCOXI C SUB 5 O FENILO OPCIONALMENTE SUSTITUIDO POR HALOGENO, TRIHALOMETILO O ALQUILO C SUB 1 SUB 8 O GRUPO ALQUILO DE CICLOALQUILO C SUB 1 NDE DICHO CICLOALQUILO ES OPCIONALMENTE SUSTITUIDO POR ALQUILO C SUB 1 SUB 6 O FENILENO; X ES UN ENLACE, -, SI (R''R") -, VINILENO O ISOPROPENILENO, SIENDO CADA R'' Y R" HIDROGENO, FLUOR O ALQUILO C SUB 1 HIDROGENO, ALQUILO C SUB 1 SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS; SON UTILES EN EL TRATAMIENTO DE UN ESTADO DE ENFERMEDAD RELACIONADO CON EL AUMENTO DE LA SINTESIS A SUB 2 (TXA SUB 2) DE TROMBOXANO.
ES91904730T 1990-02-27 1991-02-26 Derivados 1-(alcoxiiminoalquil)imidazol sustituidos. Expired - Lifetime ES2074263T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909004347A GB9004347D0 (en) 1990-02-27 1990-02-27 Substituted 1-(alkoxy-iminoalkyl)-imidazole derivatives
GB909027551A GB9027551D0 (en) 1990-12-19 1990-12-19 Carboxy derivatives of substituted 1-(alkoxy-iminoalkyl)imidazole

Publications (1)

Publication Number Publication Date
ES2074263T3 true ES2074263T3 (es) 1995-09-01

Family

ID=26296723

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91904730T Expired - Lifetime ES2074263T3 (es) 1990-02-27 1991-02-26 Derivados 1-(alcoxiiminoalquil)imidazol sustituidos.

Country Status (19)

Country Link
US (1) US5280033A (es)
EP (1) EP0469125B1 (es)
JP (1) JPH04505464A (es)
KR (1) KR920701168A (es)
AT (1) ATE117995T1 (es)
AU (1) AU644632B2 (es)
CA (1) CA2053256A1 (es)
DE (1) DE69107137T2 (es)
DK (1) DK0469125T3 (es)
ES (1) ES2074263T3 (es)
FI (1) FI915056A0 (es)
GR (1) GR3015820T3 (es)
HU (1) HU209471B (es)
IE (1) IE67286B1 (es)
IL (1) IL97144A (es)
MY (1) MY105343A (es)
NZ (1) NZ237168A (es)
PT (1) PT96895A (es)
WO (1) WO1991013062A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116470D0 (en) * 1991-07-30 1991-09-11 Erba Carlo Spa 2-(imidazol-1-yl)-benzylethylidene-aminoxyalkanoic acid derivatives
GB9302599D0 (en) * 1993-02-10 1993-03-24 Erba Carlo Spa 2-(imadazol-l-yl)-heteroaryl-propylidene-aminoxyalkanoic acid derivatives
GB9315058D0 (en) * 1993-07-20 1993-09-01 Erba Carlo Spa 2-(imidazol-1-yl)benzylethylidene-aminooxylkyl-hydroxamic acid derivatives
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
TW200510279A (en) * 2003-03-13 2005-03-16 Ono Pharmaceutical Co Iminoether derivative compound and medicament containing same as active ingredient
WO2021057696A1 (zh) * 2019-09-27 2021-04-01 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4352804A (en) * 1978-07-25 1982-10-05 Acf Chemiefarma Nv Oxime ethers, their preparation and pharmaceutical compositions containing them
DE2944446A1 (de) * 1979-11-03 1981-06-11 Bayer Ag, 5090 Leverkusen Trisubstituierte benzyl-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
EP0034249B1 (en) * 1980-02-08 1984-10-24 Gruppo Lepetit S.P.A. New naphthimidazole and naphthoxazole derivatives, their preparation, and their use in pharmaceuticals
DE3116888A1 (de) * 1981-04-28 1982-11-11 Bayer Ag, 5090 Leverkusen "azolylpropyl-oximino-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren"
EP0132771A2 (de) * 1983-07-22 1985-02-13 Hoechst Aktiengesellschaft Neue 1,2 Diaryl-3-azolyl-propan-Derivate, ihre Herstellung und Verwendung als Pflanzenbehandlungsmittel
DE3334220A1 (de) * 1983-09-22 1985-04-11 Bayer Ag, 5090 Leverkusen 1-azolyl-substituierte oximether
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3545085A1 (de) * 1985-12-19 1987-07-02 Bayer Ag Substituierte cyclopropyl-oximether

Also Published As

Publication number Publication date
EP0469125B1 (en) 1995-02-01
IL97144A0 (en) 1992-05-25
KR920701168A (ko) 1992-08-11
HU913625D0 (en) 1992-03-30
WO1991013062A2 (en) 1991-09-05
DK0469125T3 (da) 1995-03-27
MY105343A (en) 1994-09-30
FI915056A7 (fi) 1991-10-25
IE910647A1 (en) 1991-08-28
HUT59910A (en) 1992-07-28
AU644632B2 (en) 1993-12-16
DE69107137T2 (de) 1995-06-01
FI915056A0 (fi) 1991-10-25
DE69107137D1 (de) 1995-03-16
HU209471B (en) 1994-06-28
EP0469125A1 (en) 1992-02-05
JPH04505464A (ja) 1992-09-24
ATE117995T1 (de) 1995-02-15
NZ237168A (en) 1992-07-28
GR3015820T3 (en) 1995-07-31
CA2053256A1 (en) 1991-08-28
AU7304391A (en) 1991-09-18
IE67286B1 (en) 1996-03-20
IL97144A (en) 1994-11-28
WO1991013062A3 (en) 1991-10-17
US5280033A (en) 1994-01-18
PT96895A (pt) 1991-10-31

Similar Documents

Publication Publication Date Title
NO308300B1 (no) Heterosykliske forbindelser med tachykininreseptorantagonistaktivitet, og preparat inneholdende disse
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
NO303632B1 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder samt preparat inneholdende et slikt derivat
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
NO306237B1 (no) Anvendelse av xantinderivater som antidepressive midler
DE59209292D1 (de) Azol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2074263T3 (es) Derivados 1-(alcoxiiminoalquil)imidazol sustituidos.
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
CO4410329A1 (es) Nuevos pirrolocarbazoles
ES2098158T3 (es) Derivados de imidazo(1,2-a)pirazina-4-ona, utiles como antagonistas de los receptores ampa y nmda.
ES2128668T3 (es) Agonistas del receptor de 5-ht4.
DK431784A (da) Oxopyrimidin-derivater og farmaceutiske praeparater som indeholder dem
RU94002329A (ru) Модифицированные олигодезоксирибонуклеотиды, композиция, способ лечения и промежуточные соединения
DK0684237T3 (da) Morpholinderivater
ES541780A0 (es) Tetrahidrotienopiridinas
ES2162063T3 (es) Derivados de estirilbencimidazol como inhibidores de la proliferacion de las celulas de la musculatura lisa.
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
KR850004465A (ko) 1-아실이미다졸리논의 제조 방법
DK0782574T3 (da) Bicycliske carboxiamider som 5-HT1A-receptorligander
ES2065992T3 (es) Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.
ES2135383T3 (es) Pirido(3,4-b)pirrolo(1,2-e)(1,4,5)oxadiazepinas y compuestos analogos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ES2156617T3 (es) Derivados de 1,9-diazabiciclo(4.3.0)nona-3,8-dieno.
ATE170187T1 (de) Pyrrolothienopyrazin-verbindungen als 5ht3- rezeptoren-antagonisten
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties
ES2042395B1 (es) Procedimiento para la obtencion de derivados de 2-ciano-3-piperacinilquinoxalinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 469125

Country of ref document: ES